{
    "2020-10-27": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Unusual Options Activity Insight: Abbott Laboratories",
                "features": {
                    "keywords": [
                        "Unusual Options Activity",
                        "Abbott Laboratories"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Analyst Report: Abbott Laboratories",
                "features": {
                    "keywords": [
                        "Analyst Report",
                        "Abbott Laboratories"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Market Update: ABT, AMD, NRZ",
                "features": {
                    "keywords": [
                        "Market Update",
                        "ABT",
                        "AMD",
                        "NRZ"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "real estate"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "EU weighs buying Roche, Abbott rapid COVID tests amid limited supplies",
                "features": {
                    "keywords": [
                        "EU",
                        "Roche",
                        "Abbott",
                        "rapid COVID tests",
                        "limited supplies"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}